Growth hormone, IGF-I, and the elderly. Clues to potential therapeutic interventions.
Rosen
C J
CJ
St. Joseph Hospital, University of Maine, Bangor, USA. crosen@maine.maine.edu
D000368:Aged; D000375:Aging / Q000187:drug effects / Q000502:physiology*; D016922:Cellular Senescence / Q000187:drug effects / Q000502:physiology; D013007:Growth Hormone-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000378:metabolism* / Q000627:therapeutic use; D009133:Muscular Atrophy / Q000188:drug therapy; D009842:Oligopeptides / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use
D018972:Insulin-Like Growth Factor Binding Protein 3; D009842:Oligopeptides; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D013007:Growth Hormone-Releasing Hormone